← Leaderboards
Phaedra Ghazi
University Of Utah
$88,571
Attributed
$88,571
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $34.1K · FY2022–24$50K$37.5K$25K$12.5K$0
'22
'23
'24
Funding mix
By agency
NIH$88,571 · 1
By mechanism
F31$88,571 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Utah
Same institution · by research overlap
- John R Hoidal$5,368,103
- Nathan Michael Krah$300,331
- Aria Vaishnavi$1,168,436
- Anne C Kirchhoff$4,810,478
- Richard E Kanner$5,226,484
Others in their field
Other Rising Stars on “Diagnosis”
- David Annett · Information Management Services, Inc.$35,571,865
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Jennifer Lee O'Brien · University Of South Florida$15,110,862
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Thomas K Karikari · Wake Forest University Health Sciences$14,340,584
- John Alam · Eip Pharma, Inc.$10,411,018
Research focus
DiagnosisAutophagocytosisAggressive BehaviorAftercareBiochemical ProcessCancer CellCancer Cell LineCancer EtiologyBasic ScienceCancer PatientCell LineCell PhysiologyCellsCell SurvivalCellular StressCessation Of LifeChimeric ProteinsClinical TrialsCrispr/Cas TechnologyCancer ModelCytotoxicDependenceDetection Of NutrientEngineering
Grant awards (3)
Investigating KRAS Signaling and Autophagy Co-inhibition in KRAS-mutant Lung Cancer$21,283
F31 · FY2024 · CA · contact PI
Investigating KRAS Signaling and Autophagy Co-inhibition in KRAS-mutant Lung Cancer$34,115
F31 · FY2023 · CA · contact PI
Investigating KRAS Signaling and Autophagy Co-inhibition in KRAS-mutant Lung Cancer$33,173
F31 · FY2022 · CA · contact PI